Ott, M. G., Marmé, F., Moldenhauer, G., Lindhofer, H., Hennig, M., Spannagl, R., . . . Seimetz, D. (2012). Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites. Wiley Subscription Services, Inc., A Wiley Company.

Ott, Marion G., Frederik Marmé, Gerhard Moldenhauer, Horst Lindhofer, Michael Hennig, Rolf Spannagl, Mirko M. Essing, Rolf Linke, and Diane Seimetz. Humoral Response to Catumaxomab Correlates With Clinical Outcome: Results of the Pivotal Phase II/III Study in Patients With Malignant Ascites. Wiley Subscription Services, Inc., A Wiley Company, 2012.

Ott, Marion G., et al. Humoral Response to Catumaxomab Correlates With Clinical Outcome: Results of the Pivotal Phase II/III Study in Patients With Malignant Ascites. Wiley Subscription Services, Inc., A Wiley Company, 2012.